Pulmonary disease due to opportunistic ambient mycobacteria in non HIV-positive patients. Risk factors, symptoms, diagnosis and evolution;ENFERMEDAD PULMONAR POR MICOBACTERIAS AMBIENTALES OPORTUNISTAS EN PACIENTES SIN INFECCION POR EL VIRUS DE LA INMUNODEFICIENCIA HUMANA. FACTORES DE RIESGO, CLINICA, DIAGNOSTICO Y EVOLUCION

Archivos de Bronconeumologia

Volumn 32, Issue 4, 1996, Pages 170-175

  Martinez Moragon E ^a   Menendez R ^a   Santos, M ^a   Lorente, R ^a   Marco, V ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Diagnosis; Immunocompetent patients; Infection due to mycobacterias; Non tuberculous mycobacterias; Pulmonar infection; Risk factors; Simptomatology; Treatment

Indexed keywords

AMINOSALICYLIC ACID; CIPROFLOXACIN; CYCLOSERINE; ERYTHROMYCIN; ETHAMBUTOL; ETHIONAMIDE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COUGHING; DISEASE COURSE; DRUG SENSITIVITY; FEMALE; HUMAN; LUNG INFECTION; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM KANSASII; OPPORTUNISTIC INFECTION; RISK FACTOR; SMOKING; SYMPTOM; TREATMENT OUTCOME;

EID: 0242356825     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-2896(15)30782-1     Document Type: Article

References (27)

1. O'Brien RJ. The epidemiology of nontuberculous mycobacterial disease. Clin Chest Med 1989; 10: 407-418.
2. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979; 119: 107-159.
3. Tenholder MF, Moser RJ, Tellis CJ. Mycobacteria other than tuberculosis. Pulmonary involvement in patients with acquired immunodeficiency syndrome. Arch Intern Med 1988; 148: 953-955.
4. Contreras MA, Cheung OT, Sanders DE, Goldstein RS. Pulmonary infection with nontuberculous mycobacteria. Am Rev Respir Dis 1988; 137: 149-152.
5. Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989; 321: 863-868.
6. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis 1990; 142: 940-953.
7. Vestal AL. Procedures for isolation and identification of mycobacteria. Centers for Diseases Control Publ. n.o 79-8.230. Atlanta (Georgia): U.S. Department of Health, Education and Welfare, 1978.
8. O'Brien RJ, Geiter LJ, Snider DE. The epidemiology of nontuberculous mycobacterial diseases in the United States. Am Rev Respir Dis 1987; 135: 1.007-1.014.
9. Jenkins PA. Las micobacteriosis. BUICTER 1988; 63: 13.
10. Wallace RJ. Mycobacterium avium complex lung disease and woman. Now an equal opportunity disease [editorial]. Chest 1994; 105:6-7.
11. Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. Chest 1992; 101: 1.605-1.609.
12. Kennedy TP, Weber DJ. Nontuberculous mycobacteria. An under-appreciated cause of geriatric lung disease. Am J Respir Crit Care Med 1994; 149: 1.554-1.658.
13. Reich JM, Johnson RE. Mycobacterium avium complex lung disease in women [editorial]. Chest 1995; 107: 293-294.
14. Hernández S, Sauret J, Ausina V, Condom MJ, Rodriguez G, Luquin M et al. Enfermedad pulmonar por micobacterias ambientales oportunistas. Revision de 35 casos. Med Clin (Barc) 1990; 95: 53-56.
15. Christensen EE, Dietz GW, Ahn GH, Chapman JS, Murry RC, Anderson J et al. Initial roentgenographic manifestations of pulmonary Mycobacterium tuberculosis, M. kansasii and M. intracellularis infections. Chest 1981; 80: 132-136.
16. Aronchick JM, Miller WT. Disseminated non-tuberculous mycobacterial infections in immunosuppressed patients. Semin Roentgenol 1983; 28: 150-157.
17. Marinelli DL, Albelda SM, Williams TM, Kern JA, Iozzo RV, Miller WT. Nontuberculous mycobacterial infection in AIDS: clinical, pathologic, and radiographic features. Radiology 1986; 160: 77-82.
18. Modilevsky T, Sattler FR, Barnes PF. Mycobacterial disease in patients with human immunodeficiency virus infection. Arch Intern Med 1989; 149: 2.201-2.205.
19. Rigsby MO, Curtis AMcB. Pulmonary disease from nontuberculous mycobacteria in patients with human immunodeficiency virus. Chest 1994; 106: 913-919.
20. Banks J. Treatment of pulmonary disease caused by opportunist mycobacteria. Thorax 1989; 44: 449-454.
21. Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease. Incidence, presentation, and response to therapy in a community setting. Am Rev Respir Dis 1991; 143: 1.381-1.385.
22. Davidson PT, Khanijo V, Goble M, Moulding TS. Treatment of disease due to Mycobacterium intracellulare. Rev Inf Dis 1981; 3: 1.052-1.059.
23. Hornick DB, Dayton CS, Bedell GN, Fick RB. Nontuberculous mycobacterial lung disease. Substantiation of a less aggressive approach. Chest 1988; 93: 550-555.
24. Vidai R, Rey R, Espinar A, De March P, Melero C, Pina JM et al. Grupo de trabajo de SEPAR (Area TIR). Normativa sobre tratamiento y retratamiento de la tuberculosis. Barcelona: Ediciones Doyma, S.A., 1995.
25. Research Committee British Thoracic Society. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Thorax 1994; 49: 442-445.
26. Ahn CH, Lowell JR, Ahn SI, Hirst GA. Short course chemotherapy for pulmonary disease caused by Mycobacterium Kansasii. Am Rev Respir Dis 1983; 128: 1.048-1.050.
27. Davies PDO. Infection with Mycobacterium kansasii. Thorax 1994; 49: 435-436.